Entered strategic partnership with Otsuka Pharmaceutical Co., Ltd. for the development and commercialization of 4D-150 in the APAC region; to receive $85 million in upfront cash and expects to receive ...
Company reports Q3 2025 AUCATZYL® net product revenue of $21.1 million and deferred revenue of $7.6 million; 60 authorized treatment centers achieved ahead of targetClinical execution and data ...
From practical, everyday picks like water bottles, hoodies, and soaps, to splurge-worthy sporting equipment, and homewares to kit out their first apartment, we’ve got options for everyone on your ...